APRIL 2018 SURETY MEDICINE TELECONFERENCE:
HEARING CONSERVATION, AUDIOMETRIC TESTING, and HEARING IN NOISE TESTING IN SURETY PROGRAMS
April 2018 will bring the next Surety Medicine Teleconference, at 1
pm (1300 hrs) Eastern Time. The topic for April is "Hearing
Conservation, Audiometric Testing, and Hearing in Noise Testing in Surety
Programs.” The presenter will be a Doctor of Audiology who serves as
Army Public Health Center’s Program Manager for the Army Hearing Program.
To request additional information, email the Army Public Health Center Surety Medicine Division at:
SCHEDULE OF SURETY MEDICINE TELECONFERENCES FOR FY 2018
| 18 APR 2018 || Hearing Conservation and Audiometric Testing in Surety Programs |
| 30 MAY 2018 || Case Studies in Personnel Reliability Program Surety Management |
| 27 JUN 2018 || Diagnosis, Evaluation and Screening of Laboratory-Acquired Alpha Virus Infections |
| 18 JUL 2018 || Screening Diabetics for Reliability and Suitability in the PRP |
| 15 AUG 2018 || HIV: CD4 Counts, Antiretroviral Drugs, and Impaired Immune Functions in PRP |
| 26 SEP 2018 || Animal Worker Occupational Health Issues in the PRP |
Auto-Injector Shelf Life Extension Program:
NERVE AGENT ANTIDOTE SHELF LIFE EXTENSION PROGRAM
Three production lots of atropine nerve agent antidote auto-injectors expired 31 January 2018! In addition, many expiration date extensions for auto-injector medications expired in 2017! Check any auto-injector medication stores you have. Select the link below for additional information.
The US Food and Drug Administration (FDA) is alerting health care professionals and emergency responders that specific lots of DuoDote(R) combined nerve agent antidote auto-injectors have been approved for shelf life extensions beyond labeled expiration dates, some are now extended to
2022. Complete FDA information related to the auto-injector shelf life extension program can be found at this FDA Drug Safety Page.
Information on this page also includes the latest updates (6/26/2017) on shelf life extensions for the AtroPen(R) (atropine), CANA (diazepam), morphine sulfate, and pralidoxime chloride auto-injectors.